Published in Diabetes Care on June 01, 2006
Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol (2012) 3.91
Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc (2010) 2.09
Oxidative stress in diabetic nephropathy. Curr Med Chem (2010) 1.70
Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology (2011) 1.69
Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2008) 1.56
Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study. Arch Intern Med (2008) 1.52
AGE restriction in diabetes mellitus: a paradigm shift. Nat Rev Endocrinol (2011) 1.46
Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation. Am J Pathol (2010) 1.34
Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology (2009) 1.29
Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol (2008) 1.19
Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. Am J Pathol (2009) 1.07
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci U S A (2014) 1.04
Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes (2012) 1.00
Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Heart Fail Rev (2014) 0.97
AGEs decrease insulin synthesis in pancreatic β-cell by repressing Pdx-1 protein expression at the post-translational level. PLoS One (2011) 0.96
Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes. Diabetes Care (2012) 0.96
Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc Health Risk Manag (2007) 0.92
Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products. Inflammation (2012) 0.91
Anti-aging effect of adipose-derived stem cells in a mouse model of skin aging induced by D-galactose. PLoS One (2014) 0.90
Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep (2014) 0.89
The role of SLIT-ROBO signaling in proliferative diabetic retinopathy and retinal pigment epithelial cells. Mol Vis (2011) 0.88
Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift. J Gerontol A Biol Sci Med Sci (2012) 0.87
Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report. Cardiovasc Diabetol (2014) 0.85
Benefits of exercise intervention in reducing neuropathic pain. Front Cell Neurosci (2014) 0.85
Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment. Diabetes Care (2011) 0.84
Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol. Biomaterials (2012) 0.83
Redox homeostasis in pancreatic β cells. Oxid Med Cell Longev (2012) 0.82
Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders. Eur J Nutr (2016) 0.82
A feasibility study to develop a diabetes prevention program for young adults with prediabetes by using digital platforms and a handheld device. Diabetes Educ (2014) 0.81
Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated Modifications. J Biol Chem (2015) 0.80
Lycium barbarum polysaccharides protect human lens epithelial cells against oxidative stress-induced apoptosis and senescence. PLoS One (2014) 0.79
Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci (2013) 0.79
Effects of Allium victorialis leaf extracts and its single compounds on aldose reductase, advanced glycation end products and TGF-β1 expression in mesangial cells. BMC Complement Altern Med (2013) 0.79
Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study. Cardiovasc Diabetol (2016) 0.79
Glycated hemoglobin and its spinoffs: Cardiovascular disease markers or risk factors? World J Cardiol (2015) 0.77
Correlation of advanced glycation endproducts estimated from skin fluorescence in first-degree relatives: the impact of adjustment for skin pigmentation. J Diabetes Sci Technol (2014) 0.77
Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies? Cell Mol Neurobiol (2015) 0.77
Protective Effects of the Mushroom Lactarius deterrimus Extract on Systemic Oxidative Stress and Pancreatic Islets in Streptozotocin-Induced Diabetic Rats. J Diabetes Res (2015) 0.76
Extract of Adenanthera pavonina L. seed reduces development of diabetic nephropathy in streptozotocin-induced diabetic rats. Avicenna J Phytomed (2012) 0.76
The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected Individuals. Mediators Inflamm (2016) 0.76
Effect of Advanced Glycation End Products on Human Thyroglobulin's Antigenicity as Identified by the Use of Sera from Patients with Hashimoto's Thyroiditis and Gestational Diabetes Mellitus. Int J Endocrinol (2015) 0.75
High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study. Diabetes Care (2016) 0.75
A new glycation product 'norpronyl-lysine,' and direct characterization of cross linking and other glycation adducts: NMR of model compounds and collagen. Biosci Rep (2014) 0.75
(-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice. PLoS One (2017) 0.75
Glycated Albumin is Independently Associated With Arterial Stiffness in Non-Diabetic Chronic Kidney Disease Patients. Medicine (Baltimore) (2016) 0.75
Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial. BMC Endocr Disord (2014) 0.75
Nuclear factor E2-related factor 2 knockdown enhances glucose uptake and alters glucose metabolism in AML12 hepatocytes. Exp Biol Med (Maywood) (2017) 0.75
Preterm birth and future risk of maternal cardiovascular disease - is the association independent of smoking during pregnancy? BMC Pregnancy Childbirth (2015) 0.75
Pectin lyase-modified red ginseng extract exhibits potent anti-glycation effects in vitro and in vivo. J Exerc Nutrition Biochem (2017) 0.75
Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes. Glycoconj J (2016) 0.75
High mobility group box 1 in diabetic nephropathy. Exp Ther Med (2017) 0.75
The role of glycation in the pathogenesis of aging and its prevention through herbal products and physical exercise. J Exerc Nutrition Biochem (2017) 0.75
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res (2004) 5.74
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care (2010) 3.98
Diabetes and cancer: a consensus report. CA Cancer J Clin (2010) 3.95
Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc (2010) 2.44
Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc (2004) 2.28
Exercise training for claudication. N Engl J Med (2002) 2.26
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care (2010) 2.17
Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc (2010) 2.09
Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci (2007) 2.04
Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab (2009) 2.01
Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care (2007) 1.97
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. Am J Physiol Lung Cell Mol Physiol (2006) 1.93
Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med (2002) 1.89
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes (2002) 1.87
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med (2008) 1.82
Rosiglitazone improves exercise capacity in individuals with type 2 diabetes. Diabetes Care (2005) 1.70
Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation (2003) 1.65
Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab (2009) 1.65
Dietary intake in the diabetes prevention program cohort: baseline and 1-year post randomization. Ann Epidemiol (2004) 1.64
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr (2007) 1.56
Combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes. PLoS One (2013) 1.56
Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol (2008) 1.56
Cardiac dysfunction during exercise in uncomplicated type 2 diabetes. Med Sci Sports Exerc (2009) 1.54
Functional outcome in a contemporary series of major lower extremity amputations. J Vasc Surg (2003) 1.51
Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol (2003) 1.48
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation (2002) 1.43
Claudication: exercise vs endoluminal revascularization (CLEVER) study update. J Vasc Surg (2009) 1.43
Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care (2011) 1.41
Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci (2005) 1.40
Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes. Diabetes Care (2007) 1.40
Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes (2005) 1.39
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc Natl Acad Sci U S A (2004) 1.39
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci U S A (2012) 1.38
Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am J Pathol (2007) 1.35
Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation. Am J Pathol (2010) 1.34
Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci U S A (2006) 1.32
Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis (2003) 1.31
Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab Res Rev (2002) 1.31
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis (2003) 1.31
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care (2006) 1.31
Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology (2009) 1.29
Physical activity in individuals at risk for diabetes: Diabetes Prevention Program. Med Sci Sports Exerc (2006) 1.27
Activity patterns of obese adults with type 2 diabetes in the look AHEAD study. Med Sci Sports Exerc (2010) 1.24
The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. J Vasc Surg (2008) 1.22
Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol (2008) 1.22
Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice. Atherosclerosis (2002) 1.21
Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. Hum Mol Genet (2002) 1.18
Advanced glycation end products and diabetic complications: a general overview. Hormones (Athens) (2006) 1.17
Glycotoxins: a missing link in the "relationship of dietary fat and meat intake in relation to risk of type 2 diabetes in men". Diabetes Care (2002) 1.17
Attendance and graduation patterns in a group-model health maintenance organization alternative cardiac rehabilitation program. J Cardiopulm Rehabil (2004) 1.15
Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes (2003) 1.15
Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes (2003) 1.14
Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease. Vasc Med (2007) 1.13
WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death. J Biol Chem (2009) 1.12
Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients. Arterioscler Thromb Vasc Biol (2011) 1.10
Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association. Circulation (2015) 1.08
Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. Am J Pathol (2009) 1.07
Functional outcomes and quality of life in peripheral arterial disease: current status. Vasc Med (2003) 1.07
Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. Am J Physiol Heart Circ Physiol (2007) 1.06
A patient-derived perspective of health-related quality of life with peripheral arterial disease. J Nurs Scholarsh (2002) 1.06
Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses. PLoS One (2013) 1.06
AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation. Am J Physiol Cell Physiol (2007) 1.06
High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation (2004) 1.05
CREB downregulation in vascular disease: a common response to cardiovascular risk. Arterioscler Thromb Vasc Biol (2010) 1.05
Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol (2012) 1.05
Minor depression and health status among US adults with diabetes mellitus. Am J Manag Care (2007) 1.05
Glycoxidation and inflammation in renal failure patients. Am J Kidney Dis (2004) 1.04
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci U S A (2014) 1.04
Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease. J Appl Physiol (1985) (2011) 1.03
Four-year change in cardiorespiratory fitness and influence on glycemic control in adults with type 2 diabetes in a randomized trial: the Look AHEAD Trial. Diabetes Care (2012) 1.02
Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study. Vasc Med (2009) 1.01
Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev (2011) 1.00
Evaluating effects of method of administration on Walking Impairment Questionnaire. J Vasc Surg (2003) 0.99
Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice. Lab Invest (2011) 0.99
Best practices and pearls in interdisciplinary mentoring from Building Interdisciplinary Research Careers in Women's Health Directors. J Womens Health (Larchmt) (2012) 0.98
Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am J Nephrol (2006) 0.98
Assessment of functional status and quality of life in claudication. J Vasc Surg (2011) 0.98
Peripheral arterial disease rehabilitation: a review. J Cardiopulm Rehabil (2003) 0.97
Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training. Vasc Med (2012) 0.94
Aging and glycoxidant stress. Hormones (Athens) (2008) 0.94
AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease. Am J Physiol Cell Physiol (2009) 0.93
Type 2 diabetes mellitus and exercise impairment. Rev Endocr Metab Disord (2013) 0.93
CREB mediates ERK-induced survival of mouse renal tubular cells after oxidant stress. Kidney Int (2005) 0.92
Reduction of reactive oxygen species prevents hypoxia-induced CREB depletion in pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol (2011) 0.92
Nitric oxide regulates vascular adaptive mitochondrial dynamics. Am J Physiol Heart Circ Physiol (2013) 0.91
Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes. Vasc Med (2003) 0.91
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol (2016) 0.91
The role of advanced glycation end products in the development of atherosclerosis. Curr Diab Rep (2004) 0.91
Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes? Diabetes Care (2010) 0.90
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol (2016) 0.90
Women with type 2 diabetes perceive harder effort during exercise than nondiabetic women. Appl Physiol Nutr Metab (2009) 0.89
Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle. Am J Physiol Endocrinol Metab (2006) 0.89